Clinical Trial Update: Dexamethasone Therapy in VLBW Infants at Risk of CLD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating dexamethasone therapy in very low birth weight infants at risk of bronchopulmonary dysplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Infant Bronchopulmonary Dysplasia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 3 | Status: COMPLETED